The Australian Government has put an end to the PAP SMEAR TEST era by introducing a new technology on board. The PAP Smear Test which used to help in detecting only the pre-cancerous cellular changes from 1991 is now being replaced by new technology.
For promoting improvement in the cervical cancer condition, the government has put an end on Pap Smear Test. The new changes involve new HPV technology and successful uptake of HPV vaccine by young boys and girls. Though the Pap Smear test earlier used to detect pre-cancerous cellular changes but was not effective in preventing the incidence of cervical cancer in the young age of people. Studies say HPV can cause cervical cancer. The new technology will be able to detect changes on the cervix and will also improve screening rates for women who never had a Pap test before.
Unlike PAP test which use to screen 18-69 years old women for every 2 years the new technology program will now screen HPV test for every 5 years from 25 until 74 years of age.
There are 40 different types of HPV which cause genital tract infection in most of the sexually active people. Sometimes even due to the presence of the virus, there are no symptoms. Out of these 40 types, 14 are likely to cause cervical cancer. Type 16 and type 18 are most common to cause cancer when HPV cure is not taken properly. The new test will be able to determine the cancerous cells due to HPV.
People were showing concern on the fact that the new technology is going to screen women of age 25 years. What will happen to women of age below it? It has been seen that cervical cancer is very rare in young women. Also, if the women under 25 have symptoms of cervical cancer like abnormal vaginal bleeding after intercourse then they can be screened for possible outcomes. The program also involves pre-vaccination of young boys and girls(under 25 of age) which will help in reducing the risk.
With this technology, we hope that entering a new era of testing cervical cancer will reduce the number of women diagnosed with cervical cancer.